Joint Development Pipeline
Joint Development Pipeline
Joint Development Pipeline
Partnered Programs
Modality
Project
Target
Indication
Discovery
Discovery
Pre-clinical
IND-enabling
Phase I
Partners
ADC
ADC
YBL-001
DLK1
DLK1
Solid Tumor
Solid Tumor
YBL-015
B7-H3
B7-H3
Solid Tumor
Solid Tumor
Bispecific Antibody (TCE)
Bispecific Antibody (TCE)
YBL-013
PD-L1xCD3
PD-L1xCD3
Solid Tumor
Solid Tumor
AR072
Undisclosed
Undisclosed
Solid Tumor
Solid Tumor
Monoclonal Antibody
Monoclonal Antibody
AR044
IGSF1
IGSF1
Solid Tumor
Solid Tumor
AR168
Undisclosed
Undisclosed
Autoimmune Disease
DAC
DAC
AR063
Undisclosed
Undisclosed
Solid Tumor
Solid Tumor
AI Drug
AI Drug
SP029
Undisclosed
Undisclosed
Solid Tumor
Solid Tumor
Modality
Project
Target
Indication
Discovery
Pre-clinical
IND-enabling
Phase I
Partners
ADC
YBL-001
DLK1
Solid Tumor
YBL-015
B7-H3
Solid Tumor
Bispecific Antibody (TCE)
YBL-013
PD-L1xCD3
Solid Tumor
AR072
Undisclosed
Solid Tumor
Monoclonal Antibody
AR044
IGSF1
Solid Tumor
AR168
Undisclosed
Autoimmune Disease
DAC
AR063
Undisclosed
Solid Tumor
AI Drug
SP029
Undisclosed
Solid Tumor